300 episodes
Straight From The Cutter's Mouth: A Retina Podcast Jayanth Sridhar
-
- Education
An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists
-
Episode 426: Journal Club Discussion Including Inflammation Events with Faricimab, DRCR Protocol AC Post Hoc Analysis, Outcomes of Surgery for PDR, AI Interpretation of Images
-
Episode 425: April 2024 Retinal Physician Preview Including Discussion of Pipeline Targets and Durability Based Agents for Wet Age Related Macular Degeneration and Diabetic Retinopathy
Dr. Marianeli Rodriguez joins to preview the April 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.
Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 424: Journal Club Discussion of Diabetic Retinopathy and Quality of Life Measures, Artificial Intelligence and Robotics in Ophthalmology, and Proliferative Sickle Cell Retinopathy Outcomes
Drs. Avni Finn and Sarwar Zahid join to discuss three recent publications from major ophthalmology journals.
Diabetic Retinopathy and Quality of Life (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814583)
Artificial Intelligence in Ophthalmology Review (https://www.ophthalmologyretina.org/article/S2468-6530(24)00044-7/abstract)
Proliferative Sickle Cell Retinopathy Surgical Outcomes (https://www.ophthalmologyretina.org/article/S2468-6530(24)00049-6/abstract)
Relevant Financial Disclosures: None
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More
Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.
Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 422: March 2024 Retinal Physician Preview Including Discussion of Geographic Atrophy Treatments, Imaging for AMD, AMD Pipeline and More
Drs. Kat Talcott, Akshay Thomas, and Sarwar Zahid join to preview the March 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.
Relevant Financial Disclosures: Dr. Talcott and Dr. Sridhar ha consulted for Apellis and Iveric.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 421: Journal Club Discussion Including Discussion of Endophthalmitis Prophylaxis Chlorhexidine versus Povidone-Iodine, Faricimab in Treatment-Resistant AMD, Sex Disparities Systematic Review